https://www.ajmc.com/view/ajmc-roundtable-evaluating-the-management-of-cancer-immunotherapy-cit-
Stuart Genschaw, MBA, discusses how his practice approaches cancer immunotherapy (CIT) management and the potential future pathways of care.
management of cancerajmcroundtableimmunotherapycit
https://www.myocardialsolutions.com/news-article/new-proact-study-evaluates-myostrain-in-the-detection-and-management-of-cardiotoxicity
The PROactive evaluation of function to Avoid Cardio-Toxicity (PROACT; NCT03862131) clinical trial has started at Washington University School of Medicine and...
in thenewstudyevaluatedetection
https://pubmed.ncbi.nlm.nih.gov/35410760/
This survey has highlighted where consistencies and variations exist in the multidisciplinary management of breast cancer LRR. However, further research is...
breast cancermarecanationalstudymanagement
https://pubmed.ncbi.nlm.nih.gov/32359832/
In conclusion, therapeutic care management was not associated with the absence of MDTm but with patient and tumor characteristics, including age, comorbidities...
colon cancermanagementpatientscomprehensiveanalysis
https://www.scirp.org/journal/papercitationdetails?paperid=79191&JournalID=1478
Background: The introduction of oncoplasticbreast surgery, with a concomitant contralateral symmetrization procedure, allows the surgical oncologist the...
breast cancertherapeuticmammoplastymanagementprospective
https://pubmed.ncbi.nlm.nih.gov/17641585/
The term locally advanced breast cancer (LABC) encompasses a heterogeneous group of breast neoplasms; in the last revision of the American Joint Committee on...
advanced breast cancermanagementlocallyminireview